BLOODSTREAM INFECTION TESTING MARKET ANALYSIS

Bloodstream Infection Testing Market - Global Forecast to 2026, by Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-Conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others) - Size, Share, Trends, and Forecast 2019 - 2026

Published In : Jul 2019
Code : CMI1727
Pages :178
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Regional Analysis

Geographical expansion of blood stream infection testing manufacturers towards North America boost the market growth

On the basis of region, the global bloodstream infection testing market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held the dominant position in the global bloodstream infection testing market in 2018, owing to preventive healthcare awareness and high adoption of the innovative products. Moreover, high diagnosis rate and developed medical facilities in this region also drives the growth of bloodstream infection testing market in North America.

Moreover, Asia Pacific is expected to witness higher growth in the forecast period, owing to high prevalence of chronic diseases in the region. The wide availability of innovative products offering better solutions to patients at marginally lower costs also drives the bloodstream infection testing market growth. For instance, in 2017, a group of researchers led by the National Cancer Center Japan (NCC), together with Toray Industries, Inc., developed a new method that could detect thirteen different cancer types with a single drop of blood.

Moreover, For instance, in 2017, Luminex Corporation announced that Japan’s Central Social Insurance Medical Council approved to provide reimbursement for two VERIGENE assays: the gram positive and negative blood culture test. This reimbursement is recommended by the Japanese Ministry of Health, Labor and Welfare. The VERIGENE system is able to detect pathogens from blood stream for various infectious diseases.